AstraZeneca plc Doubles Down On Diabetes With $4.1bn Buyout

20-12-2013 Motley FoolComments (0)

AstraZenecaPharmaceutical

VIDEO: One Fool puts AstraZeneca plc (LON:AZN) under the spotlight.

   

Read more on Motley Fool

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top